IDO1 and neoplasm: While L‐1‐methyltryptophan downregulates IDO expression and inhibits tumor immune evasion, D‐1‐methyltryptophan paradoxically upregulates IDO expression in tumor cells, promoting immune escape [49, 50, 51].